NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 23, 2017
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Purchase
Common Stock, $.001 par value
2017-05-19$0.45/sh+14,159$6,387→ 31,359 total - Purchase
Common Stock, $.001 par value
2017-05-22$0.45/sh+11,200$5,039→ 42,559 total